What is Egrifta (and what does “Egrifta” refer to)?
Egrifta is a brand name for tesamorelin, a prescription medicine used to reduce excess abdominal fat in people with HIV who have lipodystrophy (a condition that can change how the body stores fat). [1]
Egrifta vs. Egrifta SV: what’s the difference?
People often search “Egrifta wr” when comparing products or versions. The two commonly referenced forms are:
- Egrifta (tesamorelin)
- Egrifta SV (tesamorelin in a different formulation/device)
Both contain tesamorelin as the active ingredient and are used for the same general treatment goal (reducing excess abdominal fat related to HIV-associated lipodystrophy). [1]
How does Egrifta work?
Tesamorelin is a synthetic analog that helps the body increase growth hormone–releasing activity, which leads to changes in hormone signals that can reduce abdominal fat in the target patient population. [1]
How is Egrifta taken (injection schedule)?
Egrifta is administered as an injection. The specific dosing schedule depends on the exact product formulation (Egrifta vs Egrifta SV). If you tell me which one you mean, I can narrow down the typical schedule details. [1]
Why do people ask “Egrifta w r”?
Common reasons include:
- checking whether Egrifta is still available or whether there are alternatives,
- confirming whether a similar-sounding medication is the same drug,
- looking for “with” something (like “with prescriptions,” “with Medicare,” or “with HIV”), or
- searching for “Egrifta wr” as a shorthand for a comparison (e.g., vs. Egrifta SV). [1]
Side effects and safety questions people typically look up
Patients commonly search about side effects such as injection-site reactions, swelling, joint/muscle aches, or changes related to hormone effects. If you share your concern (for example, weight gain, glucose control, or specific symptoms), I can focus the answer. [1]
---
Quick clarification
Your message ends with “Egrifta wr.” What does “wr” mean in your question—are you asking about Egrifta vs Egrifta SV, Egrifta side effects, how to take it, or cost/coverage?
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021444